Keyphrases
Artificial Pancreas
5%
Automated Insulin Delivery
32%
Basal Insulin
5%
Blood Glucose
10%
Bolus
5%
Children with Type 1 Diabetes
5%
Closed-loop
17%
Closed-loop Control
28%
Closed-loop System
5%
Continuous Glucose Monitor
24%
Continuous Glucose Monitoring
46%
Continuous Subcutaneous Insulin Infusion
6%
Dexcom G6
8%
Diabetes
19%
Diabetes Technology
6%
During Pregnancy
7%
Gestational Diabetes Mellitus
7%
Glycemic Control
22%
Glycemic Outcomes
8%
Glycemic Targets
6%
Hemoglobin A1c (HbA1c)
13%
Hotels
5%
Hybrid Closed Loop
9%
Hypoglycemia
28%
Inhaled Insulin
7%
Insulin
11%
Insulin Delivery
7%
Insulin Dose
5%
Insulin Pump
13%
Medicaid
9%
Medicare
7%
Monitoring Value
6%
Multicenter Trial
5%
Multiple Daily Injections
8%
Older Adults
8%
Omnipod
9%
Patients with Diabetes
6%
Plasma Glucose
5%
Pregnant Women
20%
Randomized Controlled Trial
8%
Randomized Trial
5%
Sensor-augmented Pump
8%
Technosphere Insulin
7%
Time in Range
13%
Tubeless
12%
Type 1 Diabetes Mellitus (T1DM)
100%
Type 2 Diabetes Mellitus (T2DM)
19%
Type I Diabetes
96%
United States
8%
Women with Diabetes
8%
Medicine and Dentistry
Adolescence
8%
Adverse Event
6%
Antidiabetic Agent
5%
Arm
11%
Blood Glucose Monitoring
5%
Clinical Trial
5%
Diabetes
46%
Diabetes Mellitus
7%
Gestational Diabetes
10%
Glycemic
15%
Glycemic Control
15%
Hemoglobin A1c
18%
Hypoglycemia
17%
Insulin Dependent Diabetes Mellitus
65%
Insulin Infusion
7%
Insulin Pump
20%
Maturity Onset Diabetes of the Young
11%
Medicare
7%
Randomized Controlled Trial
5%